Visine Totality Multi-Symptom Relief Interactions
There are 49 drugs known to interact with Visine Totality Multi-Symptom Relief (tetrahydrozoline/zinc sulfate ophthalmic), along with 4 disease interactions. Of the total drug interactions, 6 are major, and 43 are moderate.
- View all 49 medications that may interact with Visine Totality Multi-Symptom Relief
- View Visine Totality Multi-Symptom Relief disease interactions (4)
Most frequently checked interactions
View interaction reports for Visine Totality Multi-Symptom Relief (tetrahydrozoline / zinc sulfate ophthalmic) and the medicines listed below.
- Advil (ibuprofen)
- albuterol
- amlodipine
- amphetamine / dextroamphetamine
- Aspirin Low Strength (aspirin)
- atorvastatin
- azelastine nasal
- Centrum (multivitamin with minerals)
- Centrum Silver (multivitamin with minerals)
- cephalexin
- Claritin (loratadine)
- clindamycin
- clobetasol topical
- Combigan (brimonidine / timolol ophthalmic)
- cranberry
- docusate
- doxycycline
- ezetimibe
- Flexeril (cyclobenzaprine)
- Flonase (fluticasone nasal)
- ibuprofen
- Lexapro (escitalopram)
- lisinopril
- loratadine
- meloxicam
- metformin
- Tylenol Extra Strength (acetaminophen)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Zyrtec (cetirizine)
Visine Totality Multi-Symptom Relief disease interactions
There are 4 disease interactions with Visine Totality Multi-Symptom Relief (tetrahydrozoline / zinc sulfate ophthalmic) which include:
Report options
QR code containing a link to this page
More about Visine Totality Multi-Symptom Relief (tetrahydrozoline / zinc sulfate ophthalmic)
- Visine Totality Multi-Symptom Relief consumer information
- Compare alternatives
- Reviews (78)
- Side effects
- Dosage information
- During pregnancy
- Drug class: ophthalmic antihistamines and decongestants
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.